SAT0151 EFFICACY AND SAFETY OF UPADACITINIB VERSUS ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-CHOICE): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

Publication | Closed Access

DOI

Citations

References

2020

Year

Andrea Rubbert‐Roth, Jeffrey Enejosa, Aileen L. Pangan, Ricardo Machado Xavier, Boulos Haraoui, Maureen Rischmueller, N. Khan, Y. Zhang, Naomi Martin, M. C. Genovese

Annals of the Rheumatic Diseases